About Panosome
At Panosome we are making the most challenging target classes such as carbohydrates, peptides and small molecules addressable to antibodies. Spun out of the German Cancer Research Center in 2020, we are using the revolutionary VAST technology to address antibody targets in several indications, ranging from cancer to autoimmune diseases.
- Founding: 2020
- Focus : Manufacturer
- Employees: 1-10
- Industry : Biotechnology, Pharma
Product portfolio of Panosome
Here you will find Panosome GmbH
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
